Shanyong Zhang
126 Xinmin Street
Changchun, 130021, China
Changchun, 130021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Hydrogel-Based Immunomodulation of Tumor Immune Microenvironment in Hepatocellular Carcinoma: Current Strategies and Future Directions.
Journal: International journal of nanomedicine
Published: October 22, 2025
Corrigendum: Case Report: Surgical treatment of a primary giant epithelioid hemangioendothelioma of the spine with total en-bloc spondylectomy.
Journal: Frontiers in oncology
Published: October 06, 2023
Enhanced bone regeneration via local low-dose delivery of PTH1-34 in a composite hydrogel.
Journal: Frontiers in bioengineering and biotechnology
Published: April 25, 2023
Case report: Surgical treatment of a primary giant epithelioid hemangioendothelioma of the spine with total en-bloc spondylectomy.
Journal: Frontiers in oncology
Published: December 01, 2022
KLF9 and EPYC acting as feature genes for osteoarthritis and their association with immune infiltration.
Journal: Journal of orthopaedic surgery and research
Published: May 13, 2022
Correction: Long non-coding RNA DSCAM-AS1 upregulates USP47 expression through sponging miR-101-3p to accelerate osteosarcoma progression.
Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire
Published: March 29, 2021
lncRNA MELTF-AS1 facilitates osteosarcoma metastasis by modulating MMP14 expression.
Journal: Molecular therapy. Nucleic acids
Published: February 07, 2021
Long non-coding RNA DSCAM-AS1 upregulates USP47 expression through sponging miR-101-3p to accelerate osteosarcoma progression.
Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire
Published: May 08, 2020
[Corrigendum] TUSC8 inhibits the development of osteosarcoma by sponging miR‑197‑3p and targeting EHD2.
Journal: International journal of molecular medicine
Published: February 13, 2020
TUSC8 inhibits the development of osteosarcoma by sponging miR‑197‑3p and targeting EHD2.
Journal: International journal of molecular medicine
Published: February 13, 2020
Loratadine Alleviates Advanced Glycation End Product-Induced Activation of NLRP3 Inflammasome in Human Chondrocytes.
Journal: Drug design, development and therapy
Published: December 23, 2019
Last Updated: 09/26/2026